Biotech

uBiome is jumping into therapeutics with a healthy $83 million in Series C financing

23andMe, IBM and now uBiome is the next tech company to jump into the lucrative multi-billion dollar drug discovery market. The company started out with a consumer gut health test to check whether you

As biological manufacturing moves to the mainstream, Synvitrobio rebrands and raises cash

The pace at which the scientific breakthroughs working to bend the machinery of life to the whims of manufacturing have transformed into real businesses has intensified competition in the biomanufactu

Interview with Priscilla Chan: Her super-donor origin story

Priscilla Chan is so much more than Mark Zuckerberg’s wife. A teacher, doctor and now one of the world’s top philanthropists, she’s a dexterous empath determined to help. We’ve all heard Faceb

CB Therapeutics’ lab-grown cannabinoids could unlock new medicines and make others affordable

Marijuana may still be on shaky legal ground, but the therapeutic benefits of the psychoactive molecules — cannabinoids — inside the plant are solidly established. Unfortunately, cultivation of th

George Church’s genetics on the blockchain startup just raised $4.3 million from Khosla

Nebula Genomics, the startup that wants to put your whole genome on the blockchain, has announced the raise of $4.3 million in Series A from Khosla Ventures and other leading tech VC’s such as 

HP is ‘printing’ drugs for the CDC to speed up antibiotic testing

At least 2 million people in the U.S. become infected with so-called “super bugs” and at least 23,000 people die as a direct result of these infections each year, according to the Centers

RDMD attacks rare diseases with data mined from health records

You wouldn’t expect a medical app to get its start as a Snapchat competitor. Neither did video chat startup TapTalk’s founder Onno Faber. But four years ago he was diagnosed with a rare d

Cytera CellWorks aims to bring cell culture automation to your dinner plate

Cytera CellWorks hopes to revolutionize the so-called “clean meat” industry through the automation of cell cultures — and that could mean one day, if all goes to plan, the company&#

Home run exits happen stealthily for biotech

Joanna Glasner Contributor More posts by this contributor Bots replacing office workers drive big valuations The alumni of these universities raised the most VC in the past year Startup exit tallies c

Zbiotics says it’s bioengineered a hangover cure

Y Combinator backed Zbiotics has spend two years developing what they’re billing as the world’s first genetically engineered probiotic. The startup’s initial product isn’t exact

IBM Watson Health and the VA extends partnership in cancer research

IBM Watson Health and the Department of Veteran Affairs (VA) announced today their continued partnership to use Watson’s artificial intelligence to support Veterans suffering from late stage can

CRISPR DNA editing may cause serious genetic damage, researchers warn

CRISPR-Cas9, the gene editing tool that is currently the darling of biotech and many other fields, may not be quite as miraculous as early tests suggested. A new study finds that what scientists thoug

Implantable 3D-printed organs could be coming sooner than you think

At MBC Biolabs, an incubator for biotech startups in San Francisco’s Dogpatch neighborhood, a team of scientists and interns working for the small startup Prellis Biologics have just taken a big

Priscilla Chan to discuss Chan Zuckerberg Initiative at Disrupt SF

The Chan Zuckerberg Initiative is one of the biggest philanthropic organizations in the world, and the most technology-forward foundations in history. By integrating technology, CZI believes it can a

Meet the speakers at The Europas, and get your ticket free (July 3, London)

Excited to announce that this year’s The Europas Unconference & Awards is shaping up! Our half day Unconference kicks off on 3 July, 2018 at The Brewery in the heart of London’s “Tech Ci

BrainQ raises $5.3M to treat neurological disorders with the help of AI

BrainQ, an Israel-based startup that aims to help stroke victims and those with spinal cord injuries treat their injuries with the help of a personalized electromagnetic treatment protocol, today anno

A life sciences firm run by a top VC and a cofounder of Alphabet’s life sciences arm, just raised its biggest fund yet

There’s no end to the number of fascinating devices and therapies being created right now in the fields of health and life sciences. The investors behind them are often pretty interesting, too,

Mammoth Biosciences launches a CRISPR-powered search engine for disease detection

Most people tend to think of CRISPR as a groundbreaking gene-editing technology that can hunt down and snip away bits of DNA, like the cut and paste function on a keyboard. While many research project

ReviveMed turns drug discovery into a big data problem and raises $1.5M to solve it

What if there's a drug that already exists that could treat a disease with no known therapies, but we just haven't made the connection? Finding that connection by exhaustively analyzing complex biomec

MIT cuts ties with brain preservation startup Nectome

MIT is disassociating itself from Nectome, the Y Combinator-backed startup promising to preserve customers’ brains for the possibility of future digital upload. Co-founder Robert McIntyre descri
Load More